Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy
- 1 June 1997
- Vol. 49 (6) , 887-893
- https://doi.org/10.1016/s0090-4295(97)00107-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PSA‐detected prostate cancer: Contrasts with palpable diseaseJournal of Surgical Oncology, 1995
- The Pathological Features and Prognosis of Prostate Cancer Detectable With Current Diagnostic TestsJournal of Urology, 1994
- The Nature of Prostate Cancer Detected Through Prostate Specific Antigen Based ScreeningJournal of Urology, 1994
- Detection and Treatment of Prostate Cancer: Perspective of the UrologistJournal of Urology, 1994
- Radical Prostatectomy for Impalpable Prostate Cancer: The Johns Hopkins Experience With Tumors Found on Transurethral Resection (Stages T1a and T1b) and on Needle Biopsy (Stage T1c)Journal of Urology, 1994
- Tumor Volume and Stage in Carcinoma of the Prostate Detected by Elevations in Prostate Specific AntigenJournal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- PSA-DETECTED (CLINICAL STAGE T1c OR B0) PROSTATE CANCERUrologic Clinics of North America, 1993
- Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentrationUrology, 1993
- The TNM classification of prostate cancerThe Prostate, 1992